dashed lines: trial onsets. Note pupil dilation, fix break, fix acquire, shown for first trial.) Scales are colour-coded. d, Cortical signals, colour-coded by imaging wavelength. e, f, Trial-triggered averages (grey lines, individual trials; thick lines, mean 6 s.e.m., n 5 51: at 605 nm, mean peak-to-peak amplitude 5 1.19% 6 0.08; at 530 nm, 3.47% 6 0.21). Population histograms: at 605 nm, mean 5 0.86%, s.d. 5 0.29, N 5 47 experiments; at 530 nm, mean 5 2.17%, s.d. 5 0.97, N 5 66.
Haemodynamic signals underlying functional brain imaging (for example, functional magnetic resonance imaging (fMRI)) are assumed to reflect metabolic demand generated by local neuronal activity, with equal increases in haemodynamic signal implying equal increases in the underlying neuronal activity [1] [2] [3] [4] [5] [6] . Few studies have compared neuronal and haemodynamic signals in alert animals 7, 8 to test for this assumed correspondence. Here we present evidence that brings this assumption into question. Using a dualwavelength optical imaging technique 9 that independently measures cerebral blood volume and oxygenation, continuously, in alert behaving monkeys, we find two distinct components to the haemodynamic signal in the alert animals' primary visual cortex (V1). One component is reliably predictable from neuronal responses generated by visual input. The other component-of almost comparable strength-is a hitherto unknown signal that entrains to task structure independently of visual input or of standard neural predictors of haemodynamics. This latter component shows predictive timing, with increases of cerebral blood volume in anticipation of trial onsets even in darkness. This trial-locked haemodynamic signal could be due to an accompanying V1 arterial pumping mechanism, closely matched in time, with peaks of arterial dilation entrained to predicted trial onsets. These findings (tested in two animals) challenge the current understanding of the link between brain haemodynamics and local neuronal activity. They also suggest the existence of a novel preparatory mechanism in the brain that brings additional arterial blood to cortex in anticipation of expected tasks.
We have developed a dual-wavelength optical imaging technique to (in effect) image cortical blood volume and oxygenation simultaneously in alert behaving macaques. This technique involves switching rapidly between two wavelengths: 530 nm (green, equally absorbed in oxygenated and deoxygenated haemoglobin, thus measuring total haemoglobin concentration (HbT) or 'blood volume') and 605 nm (red, absorbed about fivefold more strongly in deoxygenated than oxygenated haemoglobin, thus measuring 'oxygenation' 10 Fig. 1a and Supplementary Methods)). While imaging V1 in animals performing periodic visual tasks, we observed a hitherto unknown stimulus-independent haemodynamic signal that appeared to entrain to trial timing ( Fig. 1b ).
To study this trial-related signal in isolation, we developed a task that minimized visual input while preserving trial timing. In an otherwise completely dark room, the animal was required to fix its gaze periodically on a tiny fixation point for juice reward (point size about 1-2 arcmin, that is, about 1-2 cone diameters). The fixation point stayed on continuously, switching between two equiluminant colours to cue the animal to 'fixate' or 'relax'. It was akin to seeing nothing apart from one single twinkling star in an otherwise black night sky. Our two rhesus macaque monkeys ('V' and 'S') learned the task correctly, as evidenced by their fixation patterns ( Fig. 1c ). Both monkeys performed long sequences of correct trials, consistently holding fixation during 'fixate' periods and taking fixation breaks, if any, only during 'relax' periods.
On imaging V1 while the animals performed this task, we observed robust haemodynamic signals at the trial frequency, even though the animals were in virtually total darkness and foveal V1, the only region receiving visual input from the fixation point, lay outside our imaging area. These periodic fluctuations were seen in both the 'blood volume' (530 nm) and 'oxygenation' signals (605 nm; Fig. 1d , f). They were accompanied by periodic changes in heart rate 11 and systematic pupil dilation 12 on trial onset, suggesting a rhythmic state of alertness synchronized to each trial ( Fig. 1c-f ).
We wanted to determine the relation between these trial-linked haemodynamic signals and V1 neuronal activity. A crucial assumption in most brain imaging studies is that haemodynamic signals are caused by local neuronal responses through a uniform underlying mechanism 1-6 (but see refs 13, 14) . In particular, brain images are routinely used to infer changes in local neuronal activity by fitting the imaging signal with some standard causal haemodynamic kernel. To reveal neuronal mechanisms underlying V1 haemodynamics, we obtained both trial-related and visually evoked optical imaging signals concurrently with electrode recordings across V1 (Supplementary Fig. 1 and Supplementary Table 1 ). At each site, in alternating blocks (20-40 trials each) while the animal performed the same fixation task, we presented either vigorous visual stimuli or no stimuli at all. For each data set we then used an optimization routine to calculate the causal kernel that 'best' fitted haemodynamics to concurrent neuronal signals ( Supplementary Fig. 2 ), and tested whether this 'best' kernel could reliably predict haemodynamics.
To get measures of neuronal activity for this analysis, we separated the electrode recordings into multi-unit spiking (MUA) and local field potential (LFP) ( Supplementary Fig. 1 and Supplementary Methods). As expected, visual stimulation evoked vigorous responses in both MUA and LFP ( Fig. 2a ). The stimulus-evoked LFP responses could be empirically separated into two distinct frequency bands (Fig. 2a , bottom). The high-frequency band (hi-LFP: 66-130 Hz, avoiding 60 Hz), like MUA, showed crisp, visually evoked responses. The low-frequency band (lo-LFP: 10-56 Hz), also showed a robust signal but with no apparent correlation with visual stimulation. Our empirically defined LFP bands match categories defined through previous work. The hi-LFP matches a frequency band ('high gamma') that is shown to correlate well with stimulus-evoked spiking and haemodynamics 2, 15, 16 . The lo-LFP-often separated into finer frequency bands 15, 16 -is believed to have a very different relationship with other brain signals 15, 16 . We therefore decided to test the three neuronal signal types, MUA, hi-LFP and lo-LFP, independently for their ability to predict concurrently recorded haemodynamics reliably. These tests were conducted separately for 'blood volume' and 'oxygenation' signals.
Visually driven MUA and hi-LFP predicted the simultaneously recorded haemodynamic signals very well both in amplitude and time course ( Fig. 2b-e and Supplementary Fig. 3b-e ). Further, the optimal kernels obtained by fitting these signals were consistent in shape across all recording sites ( Fig. 2c and Supplementary Fig. 3c , top); kernels from any given experiment predicted visually evoked responses in all other experiments with almost equal accuracy, attesting to their remarkable reliability ( Supplementary Fig. 4 ). In sharp contrast, the same kernels, when convolved with dark-room MUA or hi-LFP, were uniformly poor at predicting trial-related haemodynamics, in both amplitude and temporal correlation ( Fig. 2b-e and Supplementary Fig. 3b-e ). The latter finding (R 2 , 0.08, MUA; 0.06, hi-LFP) specifically implies that there is no consistent temporal relation between predicted and measured haemodynamics, independent of amplitude. This poor predictability was particularly striking because the trial-related haemodynamic signal amplitudes were almost comparable to those of responses to vigorous visual stimulation (37% at 'blood volume', 530 nm; 57% at 'oxygenation', 605 nm ( Supplementary Fig. 5) ). To check whether trial-related haemodynamics could still be predicted reliably by concurrent neuronal recordings but through kernels of a different shape, we fitted darkroom MUA and hi-LFP to dark-room haemodynamics. These 'best' dark-room kernels were highly variable among recording sites and, again, consistently failed to predict trial-related haemodynamics (Fig. 2c-e and Supplementary Fig. 3c-e, bottom) . The same overall pattern of results was seen for both 'blood volume' and 'oxygenation' signals ( Supplementary Fig. 6 ).
These results provide compelling evidence that visually evoked haemodynamic signals are very well predicted by established measures of local neuronal activity (MUA, hi-LFP) through a causal kernel that is uniform across experiments. Such a model fails profoundly, however, to predict the trial-related signals. Therefore any neuronal mechanisms underlying trial-related haemodynamics appear to be distinct from those typically assumed to underlie neurovascular coupling.
Unlike MUA or hi-LFP, lo-LFP-whether treated as a whole or separated into finer frequency bands-failed to show any consistent relationship with haemodynamics. These signals gave highly variable 'optimal kernels' when fitted with concurrent haemodynamics either under visual driving or in the dark, with uniformly poor predictions of haemodynamics ( Supplementary Figs 7 and 13 ).
Next, we characterized the novel trial-related haemodynamic signal in terms of its temporal relation to trial timing. To determine whether our observed signals are linked specifically with trial timing and not a result of some unrelated intrinsic oscillatory process 17 , we examined how the signals adapted to different trial periods. Our results provided compelling evidence that the signals are linked predictively to trial onsets. This was seen both in the signal shapes at each trial period and their anticipatory timing on switching trial period.
We found that the trial-related signals stretched elastically to match each tested trial period ( Fig. 3 and Supplementary Fig. 8a ; tested 6-s to 30-s trial periods). In particular, the shape of the 'blood volume' signal always stretched so as to start darkening (increasing haemoglobin) during the 'relax' period-before the onset of the next trial-reaching a peak darkening close to the onset of the next 'fixate' period (Figs 1  and 3a-d) . This elastic pattern of trial-locked haemodynamics-in which signals begin changing before trial onsets-cannot be explained by mechanisms that involve a causal kernel triggered on trial start. This can be demonstrated by comparison with responses to (brief, intense) visual stimulation of the same duration as the 'fixate' period, where the stereotyped response shape, with abrupt onset and fixed width after stimulus presentation, is independent of trial period ( Supplementary Fig. 8b ; quantitative model, Supplementary Fig. 8c ). The trial-related signal is thus unlikely to be due to neuronal signals active only during the cued 'fixate' period (for example, the presumed time course of 'attention' 18 ).
On switching trial timing unexpectedly after the monkey had established a rhythm of 10-20 correct trials at a given period, haemodynamic signals continued to oscillate at the earlier period for a couple of trials before entraining to the new one (Fig. 3e, f) . This Dotted white line as in c. g, Left: short-to-long transition trial (green) is statistically indistinguishable from other short trials over one short-trial period (blue background). (Bootstrap analysis. Green: mean transition trial; grey: means of 500 random N 5 16-trial subsets of the short trials to match statistics of transition trial; black: grand mean of all short trials, same as b; inset histogram: correlation of random subsets with grand mean; arrowhead: correlation of transition trial with grand mean 5 0.97.) Right: short-to-long transition response is distinct from random N 5 16-trial subsets of long trials. Same conventions as on the left, with the correlation coefficients being calculated, again, over the duration of one short period (pink background). NATURE | Vol 457 | 22 January 2009 LETTERS occurred even though the animal itself picked up the new trial pace immediately, holding and breaking fixation at the new rhythm right after the switch (that is, clearly having noticed the new pace of fixation cues). Thus, on switching from short to long trials the measured signals showed a peak darkening at the short-trial spacing even though the animal was fixating correctly at the longer period ( Fig. 3e) . Similarly, on switching from long to short trials the cortical signal continued at its previous slower pace for one long period, overriding the first few short trials (Fig. 3f) . The response shape observed on transition trials closely resembled pre-transition responses for the duration of the pre-transition trial period, while being very poorly matched to the post-transition trial shape, suggesting that the underlying neuronal mechanism continued to 'anticipate' the pre-transition trial timing ( Fig. 3g and Supplementary  Fig. 9 ). Further, the trial-related signal timing was correlated specifically with trial onsets and not with reward 19 : the peak darkening position remained unaffected on delaying the reward associated with each trial ( Supplementary Fig. 8d ).
Finally, images of the cortical surface suggested that the trialrelated signals involve the local vasculature rather than being a systemic trial-locked autonomic (for example, cardiac) response 20 . These images revealed a dramatic contraction-dilation cycle in V1 arteries, evidenced by a prominent brightening, followed by darkening of the arterial walls relative to the 'parenchyma' baseline ( Fig. 4a,  b and Supplementary Fig. 10 ; Supplementary Fig. 11 indicates how arteries, veins and 'parenchyma' are distinguished and how the arterial signal is measured). This arterial signal had a timing that closely matched the overall timing of the mean 'blood volume', with peaks of arterial contraction and dilation coinciding with peaks of brightening (decreased haemoglobin) and darkening (increased haemoglobin), respectively (Fig. 4a, c-g) . The arterial cycle stretched elastically to fit trial periods, matching the shape of the mean signal ( Fig. 4d, e ). Further, on switching trial periods, the arterial cycle showed an anticipatory dilation that was well synchronized with the anticipatory increase in 'blood volume' seen in the mean signal ( Fig. 4f, g) . This local arterial cycle may thus be the specific mechanism generating trial-related increases in V1 'blood volume' in anticipation of visual tasks. Further, the arterial cycle is seen in V1 only for visual tasks and is likely not a passive consequence of trial-locked changes in heart rate or blood pressure 20 . We found no V1 arterial pumping or trialrelated changes in V1 'blood volume' in a periodic auditory control task, despite the presence of periodic changes in heart rate and pupil dilation very similar to those seen in our visual task ( Supplementary  Fig. 12 ).
Our findings have two major implications: one for the interpretation of brain imaging 21 , the other advancing our knowledge of brain mechanisms underlying anticipation. First, the interpretation of fMRI 22 , for example, through general linear modelling 23 , typically makes the crucial assumption of a uniform linear predictive relationship between neuronal and haemodynamic signals. We show that this model is valid for visually evoked signals, but that it fails profoundly to predict another class of signals, of almost comparable magnitude and behaviourally linked structure. These results raise the further possibility that there may be other, hitherto uncovered exceptions 13, 14 to the assumption that haemodynamic signals uniformly imply equivalent underlying neuronal activity. Second, the predictive timing and arterial contraction-dilation cycle that we observe in the trial-related haemodynamic signal suggests that it could reflect a novel anticipatory brain mechanism. This mechanism could play the role of preparing cortex for anticipated tasks by bringing additional arterial blood in time for task onsets. The question of the mechanism driving this signal (for example, distal neuromodulatory control of cerebral arteries?) and its functional consequences remains a challenge for future investigations.
METHODS SUMMARY
Results were obtained using continuous, dual-wavelength intrinsic-signal optical imaging and electrode recording in two monkeys engaged in either visual fixation tasks or auditory control tasks. Standard alert-monkey optical imaging techniques 24 were used to record the intrinsic cortical signal, continuously, through a clear silicone artificial dura and glass-fronted recording chamber implanted over the V1 of the animals. The primary innovation here consisted of our using two imaging wavelengths. Two arrays of fast, high-intensity lightemitting diodes at the two wavelengths (530 nm, 605 nm) were switched on and off alternately in synchrony with the camera, thus illuminating the brain surface alternately with each wavelength on successive camera frames (15 frames per second). The illumination alternated much faster than typical haemodynamic signal timescales giving, in effect, simultaneous optical imaging at both wavelengths at 7.5 frames per second. Increased absorption (darkening) at 530 nm indicated an increase in total haemoglobin ('blood volume'). Increased absorption at 605 nm primarily indicated an increase in deoxyhaemoglobin, from a combination of increased deoxygenation and blood volume.
For the dark-room fixation task, in a completely dark room, with a mask covering even the stimulus presentation monitor, the animal was cued to fixate or relax by the colour of a fixation point visible through a pinhole in the mask (size 1-2 arcmin), typically switching between equiluminant green ('fixate') and red ('relax'). We dark-adapted alongside the animal to confirm that nothing else Supplementary Fig. 11 , method for calculating arterial signal; arterial trace shifted vertically from overall mean for visibility). c, Timing of peak arterial contraction (dilation), as phase within trial, matches peak brightening (darkening) of mean signal: red square (black diamond) respectively. d-g, Arterial signal (grey) closely matches mean signal (green) for different trial periods (d, e) and at transitions between periods (f, g); same experiment, conventions as in Fig 3b , c, f, g (traces shifted vertically for visibility). Note close matches between corresponding peaks and troughs (arrows), indicated as in Fig. 3 .
was visible. Control experiments confirmed that the trial-related signal was independent of the brightness (range: 103), colour and size (range: 253 in area) of the fixation point.
All experimental procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committees of Columbia University and the New York State Psychiatric Institute.
